参考文献/References:
[1] VIERA A J.Predisease:when does it make sense?[J].Epidemiol Rev,2011,33:122-134.
[2] OSHIMA Y,HARUKI T,KOIZUMI K,YONEZAWA S,TAKETANI A,KADOWAKI M,et al.Practices,potential,and perspectives for detecting predisease using Raman spectroscopy[J].Int J Mol Sci,2023,24(15):12170.
[3] RODMAN W L.Cancer and precancerous conditions[J].Ann Surg,1914,59(1):47-64.
[4] LEVIN I.Changes in the tissue surrounding a growing tumor and the significance of the precancerous state[J].J Exp Med,1912,16(2):149-154.
[5] PLANTE G E.Predisease biological markers:early diagnosis and prevention of arterial hypertension[J].Metabolism,2008,57:S36-S39.
[6] BOUGNRES P.Genetics of obesity and type 2 diabetes:tracking pathogenic traits during the predisease period[J].Diabetes,2002,51(Suppl 3):S295-S303.
[7] LIU R,WANG X,AIHARA K,CHEN L.Early diagnosis of complex diseases by molecular biomarkers,network biomarkers,and dynamical network biomarkers[J].Med Res Rev,2014,34(3):455-478.
[8] CHOUDHARI N S,CHANDA S,KHANNA R,SENTHIL S,GARUDADRI C S.Diagnostic accuracy of van herick technique to detect pre-disease states of primary angle closure glaucoma in a resource constraint region[J].Ophthalmic Epidemiol,2019,26(3):175-182.
[9] BAIRD P N,SAW S M,LANCA C,GUGGENHEIM J A,SMITH III E L,ZHOU X,et al.Myopia[J].Nat Rev Dis Primers,2020,6(1):99.
[10] JONAS J B,ANG M,CHO P,GUGGENHEIM J A,HE M G,JONG M,et al.IMI prevention of myopia and its progression[J].Invest Ophthalmol Vis Sci,2021,62(5):6.
[11] FLITCROFT D I,HE M,JONAS J B,JONG M,NAIDOO K,OHNO-MATSUI K,et al.IMI-defining and classifying myopia:a proposed set of standards for clinical and epidemiologic studies[J].Invest Ophthalmol Vis Sci,2019,60(3):M20-M30.
[12] OHNO-MATSUI K,WU P C,YAMASHIRO K,VUTIPONGSATORN K,FANG Y,CHEUNG C M G,et al.IMI pathologic myopia[J].Invest Ophthalmol Vis Sci,2021,62(5):5.
[13] WANG C Y,HSU N W,YANG Y C,CHEN Y L,SHYONG M P,TSAI D C.Premyopia at preschool age:population-based evidence of prevalence and risk factors from a serial survey in Taiwan [J].Ophthalmology,2022,129(8):880-889.
[14] ZADNIK K,SINNOTT L T,COTTER S A,JONES-JORDAN L A,KLEINSTEIN R N,MANNY R E,et al.Prediction of juvenile-onset myopia[J].JAMA Ophthalmol,2015,133(6):683-689.
[15] BERTAUD S,ARAGNO V,BAUDOUIN C,LABB A.Primary open-angle glaucoma[J].Rev Med Interne,2019,40(7):445-452.
[16] WANG Z,WIGGS J L,AUNG T,KHAWAJA A P,KHOR C C.The genetic basis for adult onset glaucoma:recent advances and future directions[J].Prog Retin Eye Res,2022,90:101066.
[17] APOLO G,BOHNER A,PARDESHI A,LUNG K,TOY B,WONG B,et al.Racial and sociodemographic disparities in the detection of narrow angles before detection of primary angle-closure glaucoma in the United States[J].Ophthalmol Glaucoma,2022,5(4):388-395.
[18] GILMOUR-WHITE J A,SHAH P,CROSS V,MAKUPA W,PHILIPPIN H.Glaucoma awareness and access to healthcare:perceptions among glaucoma patients in Tanzania[J].Postgrad Med J,2015,91(1077):373-378.
[19] 朱蓉嵘,施健,杨梅,姜林娟,姜红,梁从凯,等.江苏省阜宁县50岁及以上人群原发性前房角关闭患病率调查[J].中华眼科杂志,2015,51(7):487-492.
ZHU R R,SHI J,YANG M,JIANG L J,JIANG H,LIANG C K,et al.The prevalence of appositional angle closure among adults aged 50 years or above in Funing County Jiangsu Province[J].Chin J Ophthalmol,2015,51(7):487-492.
[20] MILLER H C.The effect of diabetic and prediabetic pregnancies on the fetus and newborn infant[J].J Pediatr,1946,29(4):455-461.
[21] American Diabetes Association.Classification and diagnosis of diabetes:standards of medical care in diabetes-2021[J].Diabetes Care,2021,44(Suppl 1):S15-S33.
[22] TABK A G,HERDER C,RATHMANN W,BRUNNER E J,KIVIMKI M.Prediabetes:a high-risk state for diabetes development[J].Lancet,2012,379(9833):2279-2290.
[23] ROONEY M R,FANG M,OGURTSOVA K,OZKAN B,ECHOUFFO-TCHEUGUI J B,BOYKO E J,et al.Global prevalence of prediabetes[J].Diabetes Care,2023,46(7):1388-1394.
[24] EL SAWY S,BEKHIT M,ABDELHAMID A,ESMAT S,ASHRAF H,NAGUIB M.Assessment of early macular microangiopathy in subjects with prediabetes using optical coherence tomography angiography and fundus photography[J].Acta Diabetol,2023.[Online ahead of print].
[25] TANG Q,LI X,SONG P,XU L.Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening:developments in research and prospects for the future[J].Drug Discov Ther,2015,9(6):380-385.
[26] 中华医学会眼科学分会眼底病学组,中国医师协会眼科医师分会眼底病学组,许迅,黎晓新.我国糖尿病视网膜病变临床诊疗指南(2022年):基于循证医学修订[J].中华眼底病杂志,2023,39(2):99-124.
Fundus Disease Group of Ophthalmological Society of Chinese Medical Association,Fundus Disease Group of Ophthalmologist Branch of Chinese Medical Doctor Association,XU X,LI X X.Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J].Chin J Ocul Fundus Dis,2023,39(2):99-124.
[27] QU S,RONG A,NIU Y L,LIU X,ZHANG Y S,LIU C Y,et al.Reproducibility of macular perfusion parameters in non-proliferative diabetic retinopathy patients by two different OCTA sweep modes[J].Int J Ophthalmol,2022,15(9):1483-1487.